These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26857794)

  • 1. Dietary supplements quality analysis tools from the United States Pharmacopeia.
    Sarma N; Giancaspro G; Venema J
    Drug Test Anal; 2016; 8(3-4):418-23. PubMed ID: 26857794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series.
    Brown AC
    Food Chem Toxicol; 2017 Sep; 107(Pt A):449-471. PubMed ID: 27818322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs).
    Pawar RS; Grundel E
    Drug Test Anal; 2017 Mar; 9(3):500-517. PubMed ID: 27259162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacopeial Standards for the Quality Control of Botanical Dietary Supplements in the United States.
    Sarma N; Upton R; Rose U; Guo DA; Marles R; Khan I; Giancaspro G
    J Diet Suppl; 2023; 20(3):485-504. PubMed ID: 34699287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements.
    Melethil S
    Life Sci; 2006 Mar; 78(18):2049-53. PubMed ID: 16516243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary supplements: What's in a name? What's in the bottle?
    Marcus DM
    Drug Test Anal; 2016; 8(3-4):410-2. PubMed ID: 27072845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensuring global access to quality medicines: role of the US Pharmacopeia.
    ; ; ; Heyman ML; Williams RL
    J Pharm Sci; 2011 Apr; 100(4):1280-7. PubMed ID: 24081465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Supplements Pose Real Dangers to Patients.
    White CM
    Ann Pharmacother; 2020 Aug; 54(8):815-819. PubMed ID: 31973570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and scientific issues in the standardization of botanicals and their preparations. United States Pharmacopeia's dietary supplement verification program--a public health program.
    Srinivasan VS
    Life Sci; 2006 Mar; 78(18):2039-43. PubMed ID: 16516244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and Opportunities for Improving the Safety Assessment of Botanical Dietary Supplements: A United States Pharmacopeia Perspective.
    Oketch-Rabah HA; Roe AL; Muldoon-Jacobs K; Giancaspro GI
    Clin Pharmacol Ther; 2018 Sep; 104(3):426-429. PubMed ID: 30066384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history of efforts to regulate dietary supplements in the USA.
    Swann JP
    Drug Test Anal; 2016; 8(3-4):271-82. PubMed ID: 26593452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality specifications for articles of botanical origin from the United States Pharmacopeia.
    Ma C; Oketch-Rabah H; Kim NC; Monagas M; Bzhelyansky A; Sarma N; Giancaspro G
    Phytomedicine; 2018 Jun; 45():105-119. PubMed ID: 29778318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current regulatory guidelines and resources to support research of dietary supplements in the United States.
    Bailey RL
    Crit Rev Food Sci Nutr; 2020; 60(2):298-309. PubMed ID: 30421981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. United States pharmacopeia safety evaluation of spirulina.
    Marles RJ; Barrett ML; Barnes J; Chavez ML; Gardiner P; Ko R; Mahady GB; Low Dog T; Sarma ND; Giancaspro GI; Sharaf M; Griffiths J
    Crit Rev Food Sci Nutr; 2011 Aug; 51(7):593-604. PubMed ID: 21793723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumers' perceptions of the dietary supplement health and education act: implications and recommendations.
    Dodge T
    Drug Test Anal; 2016; 8(3-4):407-9. PubMed ID: 27072844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cGMP compliance on consumer confidence in dietary supplement products.
    Crowley R; FitzGerald LH
    Toxicology; 2006 Apr; 221(1):9-16. PubMed ID: 16469425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why Americans Need Information on Dietary Supplements.
    Dwyer JT; Coates PM
    J Nutr; 2018 Aug; 148(suppl_2):1401S-1405S. PubMed ID: 31505678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings.
    Tucker J; Fischer T; Upjohn L; Mazzera D; Kumar M
    JAMA Netw Open; 2018 Oct; 1(6):e183337. PubMed ID: 30646238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(121):34751-958. PubMed ID: 17674484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.